Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-004417-40Phase 4Terminated
Phase 4 trial of pregabalin in Peripheral neuropathic pain, sponsored by Helse Bergen. Primary endpoint: Pain intensity (Numeric Rating Scale). Started Nov 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-004417-40.